The weight loss drug Wegovy is now available as a tablet in more than 70,000 U.S. pharmacies as well as select telehealth ...

PRNewswire/ -- eMed Population Health, the leading digital health platform for GLP-1/GIP population health management, today announced it has been named a Novocare Recognized Care Provider delivering ...

Until recently, the popular weight loss treatment called Wegovy was only available in injection form. The newly-launched ...

Novo Nordisk has launched an oral Wegovy pill in the U.S., offering a lower-cost alternative to injections and intensifying ...

In a major development for obesity treatment, a popular weight-loss medication, Wegovy, is now available in tablet form in ...

Med Population Health, the leading digital health platform for GLP-1/GIP population health management, today announced it has ...

Novo Nordisk's Wegovy, the first oral GLP-1 weight-loss pill, is now in 70,000+ US pharmacies, costing $5 (£4) to $10 (£7) ...

By last November, 12% of U.S. adults were already taking a glucagon-like peptide 1 (GLP-1) medication for various reasons, ...

Now the arrival of a Wegovy pill in U.S. pharmacies feels like a line in the sand between the first and second era of ...

Losing weight is a top New Year’s resolution. But this year, doctors might prescribe more than just diet and exercise.

The US Food and Drug Administration has approved the once-daily Wegovy (semaglutide) pill to help adults with obesity or with overweight and weight-related medical problems lose weight.

WASHINGTON — US News & World Report named expansion of GLP-1 medications as the top health and nutrition trend for 2026. Tying for the second spot were wearable technology integrated with artificial ...